Sage Journals: Discover world-class research

Retricted access

Review article

First published 2019-4

Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge

Sara Pusceddu, Natalie Prinzi, Alessandra Raimondi [...]

Tumori Journal

Retricted access

Research article

First published 2000-11

Treatment of a Thyrotropinoma with Octreotide-LAR in a Patient with Multiple Endocrine Neoplasia—1

Thomas J. Taylor, Susan S. Donlon, Allen E. Bale [...]

Thyroid®

Open access

Research article

First published 2019-9

Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis

P Ryan, A McBride, D Ray [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2012-2

The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy

Zelija Velija-Asimi

Therapeutic Advances in Endocrinology and Metabolism

Open access

Research article

First published 2026

Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia,Canada

Ashley Paul, Shehara Mendis, Michael Diaz-Stewart [...]

Cancer Control

Retricted access

Research article

First published 2005-09

Analysis of Peripheral Blood T-Cell Subsets in Active Thyroid-Associated Ophthalmopathy: Absence of Effect of Octreotide-LAR on T-Cell Subsets in Patients with Thyroid-Associated Ophthalmopathy

Bijay Vaidya, Brian K. Shenton, Susan Stamp [...]

Thyroid®

Retricted access

Research article

First published 2014-11

Rationale and protocol of the MetNET-1 trial,a prospective,single center,phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors

Sara Pusceddu, Filippo de Braud, Laura Concas [...]

Tumori Journal

Retricted access

Research article

First published 2006-10

Sustained release octreotide may have a role in the treatment of malignant bowel obstruction

Cristian Massacesi, Giordano Galeazzi

Palliative Medicine

Retricted access

Research article

First published 2012-10

Atherosclerotic Risk Factors and Premature Atherosclerosis in Acromegaly Before and After 48 Months of Octreotide-LAR Treatment

S. N. Boysan, F. Kantarci, O. Celik [...]

Angiology

Retricted access

Research article

First published 2000-3

Efficacia Di Un Trattamento Con Octreotide Lar in Un Paziente Anziano Affetto Da Carcinoide Cecale

Sergio Ricci, Luca Galli

Tumori Journal

Search results